• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Aruba Networks

Aruba Networks

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Bristol-Myers Squibb’s BMS-986036 (Pegylated FGF21) Shows Consistent Improvement in Liver Fat, Liver Injury and Fibrosis in Patients with Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial

    Bristol-Myers Squibb’s BMS-986036 (Pegylated FGF21) Shows Consistent Improvement in Liver Fat, Liver Injury and Fibrosis in Patients with Nonalcoholic Steatohepatitis (NASH) in Phase 2 Trial

  2. Gilead to Present Clinical and Preclinical Data on Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017

    Gilead to Present Clinical and Preclinical Data on Nonalcoholic Steatohepatitis (NASH) at The International Liver Congress™ 2017

  3. UPDATE: How to save for retirement when politicians keep making it harder

    UPDATE: How to save for retirement when politicians keep making it harder

  4. UPDATE: How to save for retirement when politicians keep making it harder

    UPDATE: How to save for retirement when politicians keep making it harder

  5. Cybertheft Attempt on Indian Bank Resembles Bangladesh Heist

    Cybertheft Attempt on Indian Bank Resembles Bangladesh Heist

©2017 Morningstar Advisor. All right reserved.